Tocilizumab in MOG-antibody spectrum disorder: a case report.
Sign Up to like & getrecommendations! Published in 2019 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2018.11.012
Abstract: BACKGROUND Myelin oligodendrocyte glycoprotein antibody-related spectrum disorders (MOG-SD) are a heterogeneous group of inflammatory demyelinating diseases of the central nervous system, usually responsive to conventional immunosuppressive therapies. However, knowledge about treatment of non-responder patients is… read more here.
Keywords: mog antibody; antibody; spectrum; report ... See more keywords
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions
Sign Up to like & getrecommendations! Published in 2021 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/17562864211003486
Abstract: Antibodies against glutamic acid decarboxylase (GAD), originally linked to stiff person syndrome (SPS), now denote the “GAD antibody-spectrum disorders” (GAD-SD) that also include autoimmune epilepsy, limbic encephalitis, cerebellar ataxia and nystagmus with overlapping symptomatology highlighting… read more here.
Keywords: gad antibody; spectrum disorders; antibody spectrum; gad ... See more keywords